Octubre 2018
Potential utility of a positive EarlyCDT®—Lung blood biomarker test in indeterminate pulmonary nodules. Journal of Thoracic Oncology
Septiembre 2018
Development and validation of an ELISA test detecting a panel of autoantibodies in combination with AFP for early detection of hepatocellular carcinoma. ILCA, London
Mayo 2018
Cost-effectiveness of an autoantibody test (EarlyCDT®—Lung ) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules. PLOS One
Noviembre 2017
Determination of the detection lead time for autoantibody biomarkers in early stage lung cancer using the UKCTOCS cohort. Journal of Thoracic Oncology
Octubre 2017
Changes in smoking behaviour in the Early Cancer detection test Lung cancer Scotland (ECLS) study. Journal of Thoracic Oncology
Octubre 2017
Is lung cancer screening associated with a negative psychological impact? Journal of Thoracic Oncology
Octubre 2017
How does screening for the early detection of lung cancer facilitate smoking cessation? A qualitative study of screened smokers. Journal of Thoracic Oncology
Septiembre 2017
Autoantibodies as additive biomarkers to AFP for the detection of HCC. 11th Annual International Liver Cancer Association (ILCA)
Septiembre 2017
An interim report on the detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®—Lung Test in Scotland (ECLS). European Respiratory Journal
Mayo 2017
Tumor-associated autoantibodies: re-optimization of EarlyCDT®—Lung diagnostic performance and its application to indeterminate pulmonary nodules. Journal of Cancer Therapy
Marzo 2017
Autoantibody signature enhances the positive predictive power of computed tomography for detection of lung cancer. Journal of Thoracic Oncology
Marzo 2017
Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®—Lung Test (ECLS): study protocol for a randomized controlled trial. BMC Cancer
Marzo 2017
Autoantibodies: opportunities for early cancer detection. Trends in Cancer
Noviembre 2016
An RCT of the detection of autoantibodies to tumor antigens in lung cancer using the EarlyCDT®—Lung Test in Scotland (ECLS) in 12 208 study subjects. Journal of Thoracic Oncology
Octubre 2016
Analysis of the Early CDT-blood biomarker for lung cancer in higher vs. lower risk cohorts. Journal of Thoracic Oncology
Octubre 2016
Improvement in performance of an autoantibody panel test for detection of lung cancer by addition of a single novel biomarker (EDB1). Journal of Thoracic Oncology
Septiembre 2015
Screening for lung cancer with the Early CDT-Lung and computed tomography. Journal of Thoracic Oncology
Septiembre 2015
Progress with an RCT of the detection of autoantibodies to tumour antigens in lung cancer using the EarlyCDT®—Lung test in Scotland (ECLS). Journal of Thoracic Oncology
Mayo 2015
Improvement in the performance of the EarlyCDT®—Lungtest in the detection of lung cancer by the application of additional metrics to reduce false positive results. 2015 ATS Annual Meeting, Am J Respir Crit Care Med
Mayo 2015
Measuring the improvement in lung nodule cancer risk assessment when EarlyCDT®—Lung is applied to a clinically-tested high-risk cohort. 2015 ATS Annual Meeting, Am J Respir Crit Care Me
Febrero 2015
Development of a serum autoantibody assay to help with the detection of hepatocellular carcinoma.
7th Annual International Liver Cancer Association (ILCA)
Febrero 2015
Serum antibodies in ovarian cancer. Molecular Med Tri-Con 2015
Agosto 2014
Serum autoantibody measurement for the detection of hepatocellular carcinoma. PLOS One
Octubre 2013
Autoantibodies to a panel of lung cancer-associated antigens can provide significant discrimination between malignant and non-malignant lung nodules. WCLC 2013
Octubre 2013
Audit of the autoantibody test, EarlyCDT®—Lung, in 1600 patients: an evaluation of its performance in routine clinical practice. Lung Cancer Journal
October 2013
Signal stratification of autoantibody levels in serum samples and its application to the early detection of lung cancer. Journal of Thoracic Disease
Septiembre 2013
Changes in autoantibody profiles in individuals with, and at risk for, hepatocellular carcinoma. 7th Annual International Liver Cancer Association (ILCA)
Septiembre 2013
An Audit of the clinical performance of EarlyCDT®—Lung. Chicago Multidisciplinary Symposium in Thoracic Oncology (ASTRO)
Agosto 2013
Signal stratification of autoantibody levels in serum samples and its application to the early diagnosis of lung cancer. Am J Respir Crit Care Med
Diciembre 2012
Application of a high throughput method of biomarker discovery to improvement of the EarlyCDT®—Lung test. PLOS One
Noviembre 2012
Challenges in biomarker development. World Breast Cancer Report 2012
Octubre 2012
Benefits of using EarlyCDT®—Lung in clinical practice. Chest
Octubre 2012
The additive effect of the stratified EarlyCDT®—Lung serum autoantibody test on the assessment of lung cancer risk. Chest
Octubre, 2012
EarlyCDT®—Lung enhances the positive predictive power of computed tomography for detecting lung cancer. Chest
Octubre 2012
Early identification of hepatocellular carcinoma. ISOBM 2012, Tumor Biology
Octubre 2012
Early identification of lung cancer using autoantibody assays. 40th Congress of the International-Society-of-Oncology-and-Biomarkers, Volume: 33
Julio 2012
Development and validation of a high throughput system for discovery of antigens for autoantibody detection. PLOSOne
Mayo 2012
Identification of tumor-associated autoantibodies to different forms of recombinant MAGE A4. American Journal of Respiratory and Critical Care Medicine
Mayo 2012
Identification of tumour-associated autoantibodies in small-cell lung cancer as immune markers of disease. ISOBM 2012, Tumor Biology
Mayo 2012
Improved specificity of the EarlyCDT®—Lung test through additional autoantibody assays. American Journal of Respiratory and Critical Care Medicine
Abril 2012
EarlyCDT®—Lung test: improved clinical utility through additional autoantibody assays. Tumour Biology
Diciembre 2011
Serum autoantibodies to breast cancer associated antigens reflect tumour biology: an opportunity for early detection & prevention? Cancer Research Special Supplement
Octubre 2011
Autoantibodies as immunobiomarkers in lung cancer and their use in early cancer detection. Tumor Biology Supplement
Octubre 2011
Autoantibodies to p53 can predate a clinical diagnosis of ovarian cancer – a case report.
Octubre 2011
Autoantibodies in ovarian cancer. Tumor Biology Supplement
Septiembre 2011
The utility of SOX antibodies for cancer prediction in patients with paraneoplastic neurological disorders. Association of British Neurologists Annual Meeting 2011
Julio 2011
EarlyCDT®—Lung test: audit of the first 1000 patients in clinical practice. IASLT Amsterdam
Mayo 2011
Mesothlioma and tumor-associated autoantibodies. Am J Respir Crit Care Med
Mayo 2011
Demonstration of the specificity of human autoantibody responses to tumor associated antigens.
Am J Respir Crit Care Med
Mayo 2011
Cost-effectiveness of screening older adult smokers for lung cancer with an autoantibody test (AABT). Am J Respir Crit Care Med
Mayo 2011
EarlyCDT®—Lung: a newly marketed blood test to aid the early detection of lung cancer in high-risk patients – enhances the positive predictive power of computed tomography. Am J Respir Crit Care Med
Marzo 2011
EarlyCDT®—Lung: an immuno-biomarker test as an aid to early detection of lung cancer. Cancer Prevention Research
Diciembre 2010
Immuno-biomarkers in small cell lung cancer: potential early clinical signals. Clinical Cancer Research
Diciembre 2010
An improved EarlyCDT®—Lung test can be used to aid the detection of lung cancer. Chicago Multidisciplinary Symposium in Thoracic Oncology (ASTRO)
Octubre 2010
Antigen positivity in the Early CDT—Lung test by stage and histological subtype of lung cancer. Chest
Octubre 2010
The presence of autoantibodies to tumour-associated antigens can predate clinical diagnosis of lung cancer (CHEST 2010). Chest
Octubre 2010
Autoantibodies in oncology – presence and use for early disease identification. XIII International Symposium on Biology and Clinical Usefulness of Tumor Markers – Barcelona
Octubre 2010
Stage 1a non-small cell lung cancer detected by assaying autoantibodies to tumor antigens. Chest
Octubre, 2010
EarlyCDT®—Lung: QC measures reveal high precision, accuracy and robustness of a clinical test to aid in early lung cancer detection for high-risk individuals. Chest
Octubre 2010
An autoantibody test (AABT) to aid in early detection of lung cancer in high-risk patients is likely to be cost-effective. Chest
Octubre, 2010
Reproducibility of autoantibody measurements in normal individuals using the EarlyCDT®—Lung test. Chest
Septiembre 2010
The presence of autoantibodies to tumour-associated antigens can predate clinical diagnosis of lung cancer. Tumor Biology Supplement
Septiembre 2010
Does heat treatment of human serum affect the measurement of autoantibodies to recombinant tumour-associated antigens? Tumor Biology Supplement
Julio 2010
Clinical validation of an autoantibody test for lung cancer. Annals of Oncology
Junio 2010
Demographics of populations at high risk of lung cancer and results of the EarlyCDT®—Lung test. Journal of Clinical Oncology, ASCO
Junio 2010
Cost-effectiveness of an Autoantibody Test (AABT) as an aid to diagnosis of lung cancer. Journal of Clinical Oncology, ASCO
Junio 2010
Use of sSerum autoantibodies to identify early-stage lung cancer: a significant step forward in early detection. Journal of Clinical Oncology, ASCO
Mayo 2010
Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer. PLOS One
Abril 2010
Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer. Lung Cancer Journal
Febrero 2010
Technical validation of an autoantibody test for lung cancer. Annals of Oncology
Septiembre 2008
A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology
Agosto 2008
Lung cancer – can autoantibodies provide an aid to diagnosis? Expert Opinion on Medical Diagnostics
Marzo 2008
Autoantibodies in lung cancer – possibilities for early detection and subsequent cure. Thorax
Marzo 2008
The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient’s serum. Glycobiology
Enero 2008
Removal Of major bacterial contaminant SlyD after a two-step chromatography purification of recombinant protein. Peptalk
Noviembre 2007
Serum EGFR and HER-2 expression in primary and metastaic breast cancer. Breast Cancer Research
Septiembre 2007
Bacterial contaminant removal after purification of recombinant protein. BioProcess International
Junio 2007
Two-step method to isolate target recombinant protein from co-purified bacterial contaminant SlyD after immobilised metal affinity chromatography. Journal of Chromatography
Marzo 2007
Autoantibodies in breast cancer: their use as an aid to early diagnosis. Annals of Oncology
Septiembre 2006
Comparison of the autoantibody reactivity of the extracellular and intracellular domains of the tumour antigen HER-2 in breast cancer diagnosis. Tumor Biology Supplement
September 2006
Serum vs. plasma in autoantibody detection by ELISA. ISOBM 2006. Pasadena, Calif. for Oncodevelopmental Biology and Medicine, ISOBM 2006 September 16–20, 2006, Pasadena, Calif
Septiembre 2006
Autoantibodies in breast cancer: their use as an aid to early diagnosis. Tumor Biology Supplement
Abril 2006
Use of autoantibodies in breast cancer screening and diagnosis. Expert Review of Anticancer Therapy
Octubre 2005
Improvement in performance of the EarlyCDT®—Lung test for detection of lung cancer by addition of antigenic biomarkers.
Octubre 2005
Assessment of autoantibodies for prediction of disease recurrence in subjects undergoing SCIB1 vaccination for malignant melanoma.
Octubre 2005
Malignancy-induced autoimmunity to MUC1: initial antibody characterization. Journal of Peptide Research
Octubre, 2005
Cost-fffectiveness of an autoantibody test (EarlyCDT®—Lung) as an aid to detection of lung cancer. Journal of Peptide Research
Octubre 2005
Autoantibodies in lung cancer. Tumor Biology Supplement
Septiembre 2005
Serum MUC1 O-glycans from cancer patients contain the Sialyl Tn antigen.
Tumor Biology Supplement
Septiembre 2005
Human autoantibodies to CA125.